; and (2) by inserting after subsection (c) the following new subsections: (d) Pandemic influenza program The Secretary, acting through the Director of BARDA, shall establish and implement a program that— (1) supports research and development activities for qualified pandemic or epidemic products (as defined in section 319F–3(i)), including by developing innovative technologies to enhance rapid response to threats relating to pandemic influenza; (2) ensures readiness to respond to pandemic influenza threats by supporting the development and manufacturing of influenza virus seeds, clinical trial lots, and stockpiles of novel influenza strains; and (3) sustains and replenishes pandemic stockpiles of bulk antigen and adjuvant material, including annually testing the potency and shelf-life potential of all existing pandemic stockpiles held by the Department of Health and Human Services. (e) Emerging infectious disease program The Secretary, acting through the Director of BARDA, shall establish and implement a program that supports research and development, and manufacturing infrastructure, activities with respect to an emerging infectious disease. . (d) Funding Subsection (f) of section 319L of the Public Health Service Act ( 42 U.S.C. 247d–7e ), as redesignated by subsection (b)(1), is amended— (1) in paragraph (2)— (A) by inserting (other than subsections (d) and (e)) after purposes of this section ; and (B) by striking $415,000,000 for each of fiscal years 2014 through 2018 and inserting $536,700,000 for each of fiscal years 2019 through 2023